Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1B1 | Q16678 | 6/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | CYP1A1 | P04798 | 5/20 | 0.35 |
| ▸ | CA12 | O43570 | 2/20 | 0.34 |
| ▸ | CA9 | Q16790 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.32 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.32 |
| ▸ | FYN | P06241 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | AHR | P35869 | 1/20 | 0.32 |
| ▸ | GPR3 | P46089 | 1/20 | 0.32 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.32 |
| ▸ | NQO1 | P15559 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18666097 | 0.87 | MAPT (0.50) | CYP1B1ALDH1A1HPGDMAPTRAB9A | |
| SCHEMBL30581080 | 0.87 | CYP1B1 (0.46) | CYP1B1ALDH1A1HSD17B10HIF1AHPGD | |
| SCHEMBL14101422 | 0.87 | CYP1B1 (0.46) | CYP1B1ALDH1A1HSD17B10HIF1AHPGD | |
| SCHEMBL11990859 | 0.82 | GPR3 (0.46) | CYP1B1ALDH1A1HSD17B10HIF1AHPGD | |
| SCHEMBL30888167 | 0.82 | GPR3 (0.46) | CYP1B1ALDH1A1HSD17B10HIF1AHPGD | |
| SCHEMBL13562029 | 0.80 | CYP2A6 (0.46) | CYP1B1ALDH1A1HSD17B10HIF1AHPGD | |
| SCHEMBL752667 | 0.80 | GPR3 (0.43) | CYP1B1ALDH1A1HSD17B10HIF1AHPGD | |
| SCHEMBL16024612 | 0.80 | GPR3 (0.43) | CYP1B1ALDH1A1HSD17B10HIF1AHPGD | |
| SCHEMBL24341046 | 0.79 | MAPT (0.37) | CYP1B1ALDH1A1HPGDMAPTRAB9A | |
| SCHEMBL19109216 | 0.79 | MAPT (0.37) | CYP1B1ALDH1A1HPGDMAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2966077-B1 | CHALCOGEN-CONTAINING ORGANIC COMPOUND AND USE THEREFOR | JNC CORP (JP) | 2020-04-01 | — | — | EP | disclosed |
| US-9853225-B2 | Chalcogen-containing organic compound and a use thereof | JNC CORPORATION (JP) | 2017-12-26 | — | — | US | disclosed |
| US-20160013425-A1 | A CHALCOGEN-CONTAINING ORGANIC COMPOUND AND A USE THEREOF | PI-CRYSTAL INC. (JP) | 2016-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160013425-A1 | A CHALCOGEN-CONTAINING ORGANIC COMPOUND AND A USE THEREOF | SCO2, SOD1, GPX1 | CYP1B1 332/4885ALDH1A1 2158/4885HSD17B10 503/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.